WHO may drop ‘counterfeit’ from its substandard drugs definition; move won't affect national legislation

The World Health Organisation is considering a recommendation that it drops use of the term ‘counterfeit’ when referring to drugs and other medical products that appear to fail regulatory standards and lack relevant approvals.